Avidity Biosciences (NASDAQ:RNA) Shares Gap Down After Analyst Downgrade
Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report)’s stock price gapped down before the market opened on Monday after Barclays lowered their price target on the stock from $63.00 to $57.00. The stock had previously closed at $30.64, but opened at $29.90. Barclays currently has an overweight rating on the stock. Avidity Biosciences shares last […]
Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report)’s stock price gapped down before the market opened on Monday after Barclays lowered their price target on the stock from $63.00 to $57.00. The stock had previously closed at $30.64, but opened at $29.90. Barclays currently has an overweight rating on the stock. Avidity Biosciences shares last […]
